Loading...
•
Jun 30, 2020
Allscripts Q2 2020 Earnings Report
Allscripts' Q2 2020 results demonstrated resilience amidst the COVID-19 pandemic, with a strategic agreement to sell the EPSi business unit and a focus on cost structure improvements.
Key Takeaways
Allscripts announced its Q2 2020 financial results, reporting revenue of $406 million and a GAAP loss per share of $0.05. The company signed a definitive agreement to sell its EPSi business unit for $365 million and focused on improving its cost structure, which led to expanded Adjusted EBITDA margins.
Allscripts' Q2 revenue reached $406 million.
The company signed an agreement to sell its EPSi business unit for $365 million.
Non-GAAP diluted EPS grew by 6% year-over-year to $0.18.
Allscripts focused on improving its cost structure and expanding Adjusted EBITDA margins.
Revenue by Segment
Forward Guidance
Allscripts expects to remain disciplined around costs while also delivering for clients and benefit from a nimble operating model and the investments across the portfolio.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...